Previous 10 | Next 10 |
NEW HAVEN, Conn., June 04, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced that it has entered into an exclusive subcontracting manufacturing agreement with diagnostics manufacturing company Novamed for the production of Precipio...
NEW HAVEN, Conn., May 30, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), today provides shareholders with three of the key pathology performance metrics tracked by the company to ensure continuous growth of the business. These metrics de...
NEW HAVEN, Conn., May 23, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced today that, as previously stated, Ilan Danieli, Precipio’s CEO, has enrolled in a plan to purchase Precipio’s common stock on the open market in ac...
NEW HAVEN, Conn., May 15, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced that on May 15, 2019 the Company received a letter from Nasdaq informing the Company that it had regained compliance with the Bid Price Rule and the matter...
Some investors simply stay clear of penny stocks; the lower the price, the higher the volatility. So for stocks trading under $1, you can imagine the risk investors are taking when opting for some of the lowest shares on the market. However, if you are a fan of investing, you might be i...
Precipio, Inc. (PRPO) Shareholder Update Earnings Conference Call May 06, 2019, 05:00 PM ET Company Participants Miri Chiko-Radomski - In-House Counsel Ilan Danieli - CEO Ori Karev - Chief Strategy Officer Conference Call Participants Presentation Operator Good afte...
NEW HAVEN, Conn., May 06, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced that it is in the process of completing a trial of its Proprietary IV-Cell media with a significant laboratory (name undisclosed at this time). The purpose of th...
Gainers : Regional Health Properties (NYSEMKT: RHE ) +54% . Zix (NASDAQ: ZIXI ) +34% . Wesco Aircraft (NYSE: WAIR ) +28% . AAC Holdings (NYSE: AAC ) +25% . Maxar Technologies (NYSE: MAXR ) +23% . Idera Pharmaceuticals (NASDAQ: IDRA ) +22% . Mercer International (NASDAQ: M...
NEW HAVEN, Conn., May 03, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced that yesterday, in accordance with established Nasdaq protocol, the company held a hearing regarding its recent steps undertaken by it in order to regain complia...
Gainers: Diffusion Pharmaceuticals (NASDAQ: DFFN ) +49% . ARCA biopharma (NASDAQ: ABIO ) +47% . Digimarc Corporation (NASDAQ: DMRC ) +46% . Hudson Technologies (NASDAQ: HDSN ) +23% . InspireMD (NYSEMKT: NSPR ) +17% . Materion Corporation (NYSE: MTRN ) +16% . Precipio (NASD...
News, Short Squeeze, Breakout and More Instantly...
NEW HAVEN, Conn., July 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that for Q2-2024, its unaudited revenues have grown from $3.4M in Q1-2024 to $4.4M in Q2-2024, an increase of 30% from one quarter ago. Patholog...
NEW HAVEN, Conn., June 13, 2024 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) , today announced that the company’s 2024 Annual Meeting of Shareholders (“Annual Meeting”) was convened and adjourned, without any business being conducted...
NEW HAVEN, Conn., June 12, 2024 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares immediately today no later than 11pm Eastern Time. In order to e...